The CDC recently issued an advisory about a bacteria called shigella due to a nationwide increase in infections resulting from drug-resistant strains. The easily transmissible bacteria causes an infection called shigellosis that is uncomfortable and unpleasant but rarely life-threatening — the main symptom is inflammatory diarrhea.
CMS is cracking down on hospital-acquired infections, starting with MRSA and C. difficile.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The new scopes are coming primarily from smaller companies looking to challenge a handful of dominant device makers.
The collaborative brings together more acronyms than an army battle map, international drug research expertise and as much as $350 million in funding to tackle this looming crisis.
Scope devices that are difficult to clean have been called out in certain cases for causing antibiotic-resistant infections in the past. Olympus, a Japan-based device maker, failed to report infection investigations to the FDA or American hospitals, and they are now being called out.
Surfers might have a unique contribution when it comes to addressing the threat of drug-resistant bacteria.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.